These results clearly suggest that mucosal vaccination with Ad-UMAS can significantly augment Th1-mediated cellular immune responses in which CD8+ T lymphocytes are considered as major effectors responsible for controlling parasite infection and secreting IFN-γ during the cellular response against toxoplasmosis. The gene discussed is IFNG; the disease is toxoplasmosis.